201 related articles for article (PubMed ID: 9751352)
21. Pulmonary Function in Patients With Germ Cell Cancer Treated With Bleomycin, Etoposide, and Cisplatin.
Lauritsen J; Kier MG; Bandak M; Mortensen MS; Thomsen FB; Mortensen J; Daugaard G
J Clin Oncol; 2016 May; 34(13):1492-9. PubMed ID: 26903578
[TBL] [Abstract][Full Text] [Related]
22. Resection of pulmonary metastases following chemotherapy for high stage testicular tumors.
Eskicorapci SY; Ekici S; Atsu MN; Dogan R; Ozen H
Int J Urol; 2004 Aug; 11(8):634-9. PubMed ID: 15285754
[TBL] [Abstract][Full Text] [Related]
23. Improved management of abdominal undescended testicular tumors with bulky confluent retroperitoneal nodal metastases.
Kulkarni JN; Desai SM; Phadke GK; Tongaonkar HB
J Urol; 1996 Oct; 156(4):1341-4. PubMed ID: 8808867
[TBL] [Abstract][Full Text] [Related]
24. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
[TBL] [Abstract][Full Text] [Related]
25. Late pulmonary toxicity of bleomycin.
Willenbacher W; Mumm A; Bartsch HH
J Clin Oncol; 1998 Sep; 16(9):3205. PubMed ID: 9738596
[No Abstract] [Full Text] [Related]
26. Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial.
Loehrer PJ; Johnson D; Elson P; Einhorn LH; Trump D
J Clin Oncol; 1995 Feb; 13(2):470-6. PubMed ID: 7531223
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial.
Pont J; Albrecht W; Postner G; Sellner F; Angel K; Höltl W
J Clin Oncol; 1996 Feb; 14(2):441-8. PubMed ID: 8636755
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary risk factors of elective abdominal aortic surgery.
Calligaro KD; Azurin DJ; Dougherty MJ; Dandora R; Bajgier SM; Simper S; Savarese RP; Raviola CA; DeLaurentis DA
J Vasc Surg; 1993 Dec; 18(6):914-20; discussion 920-1. PubMed ID: 8264047
[TBL] [Abstract][Full Text] [Related]
29. Late pulmonary complications of treating Hodgkin lymphoma: bleomycin-induced toxicity.
Jóna Á; Miltényi Z; Ujj Z; Garai I; Szilasi M; Illés Á
Expert Opin Drug Saf; 2014 Oct; 13(10):1291-7. PubMed ID: 25135756
[TBL] [Abstract][Full Text] [Related]
30. Variation in the HFE gene is associated with the development of bleomycin-induced pulmonary toxicity in testicular cancer patients.
van der Schoot GGF; Westerink NL; Lubberts S; Nuver J; Zwart N; Walenkamp AME; Wempe JB; Meijer C; Gietema JA
Eur J Cancer; 2016 May; 59():134-141. PubMed ID: 27033261
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary toxicity in patients with advanced-stage germ cell tumors receiving bleomycin with and without granulocyte colony stimulating factor.
Saxman SB; Nichols CR; Einhorn LH
Chest; 1997 Mar; 111(3):657-60. PubMed ID: 9118704
[TBL] [Abstract][Full Text] [Related]
32. RPLND or primary chemotherapy in clinical stage IIA/B nonseminomatous germ cell tumors? Results of a prospective multicenter trial including quality of life assessment.
Weissbach L; Bussar-Maatz R; Flechtner H; Pichlmeier U; Hartmann M; Keller L
Eur Urol; 2000 May; 37(5):582-94. PubMed ID: 10765098
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy of testicular cancer: 10-year experience.
Ondrus D; Hornák M; Matoska J; Kausitz J; Belan V; Cársky S
Neoplasma; 1993; 40(4):247-53. PubMed ID: 7505886
[TBL] [Abstract][Full Text] [Related]
34. Fatal bleomycin pulmonary toxicity in the west of Scotland 1991-95: a review of patients with germ cell tumours.
Simpson AB; Paul J; Graham J; Kaye SB
Br J Cancer; 1998 Oct; 78(8):1061-6. PubMed ID: 9792151
[TBL] [Abstract][Full Text] [Related]
35. Effect of Bleomycin Administration on the Development of Pulmonary Toxicity in Patients With Metastatic Germ Cell Tumors Receiving First-Line Chemotherapy: A Meta-Analysis of Randomized Studies.
Necchi A; Miceli R; Oualla K; Sonpavde G; Giannatempo P; Raggi D; Nicolai N; Boffi R; Busia A; Mariani L; Salvioni R
Clin Genitourin Cancer; 2017 Apr; 15(2):213-220.e5. PubMed ID: 27692810
[TBL] [Abstract][Full Text] [Related]
36. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
37. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.
Logothetis CJ; Samuels ML; Selig D; Swanson D; Johnson DE; von Eschenbach AC
J Clin Oncol; 1985 Mar; 3(3):326-35. PubMed ID: 2579213
[TBL] [Abstract][Full Text] [Related]
38. Serum creatinine level during chemotherapy for testicular cancer as a possible predictor of bleomycin-induced pulmonary toxicity.
Kawai K; Hinotsu S; Tomobe M; Akaza H
Jpn J Clin Oncol; 1998 Sep; 28(9):546-50. PubMed ID: 9793027
[TBL] [Abstract][Full Text] [Related]
39. [Bleomycin-induced pulmonary infiltrations in the treatment of testicular cancer].
Clemm C; Hartenstein R; Mayr B; Wilmanns W
Klin Wochenschr; 1984 Feb; 62(3):138-44. PubMed ID: 6200644
[TBL] [Abstract][Full Text] [Related]
40. Impact of hemoglobin levels on hemoglobin-adjusted carbon monoxide diffusion capacity after chemotherapy for testicular cancer.
Nitta S; Kawai K; Nagumo Y; Ikeda A; Kandori S; Kojima T; Nishiyama H
Jpn J Clin Oncol; 2019 Dec; 49(12):1151-1156. PubMed ID: 31361805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
